Search Results
Feb 04, 2026, 09:00 ET Lummus and Sumitomo Chemical Announce Commercial Availability of PMMA Chemical Recycling Technology
Technology and Sumitomo Chemical today announced the commercial availability of their highly-efficient Polymethyl Methacrylate Chemical Recycling (PMMA-CR) technology. This builds on the strategic partnership between Lummus and Sumitomo Chemical, first announced in May 2024, to co-develop and commercialize
More news about: Lummus Technology, LLC
Feb 04, 2026, 07:48 ET AbbVie Reports Full-Year and Fourth-Quarter 2025 Financial Results
overall response (OR) rates compared to standard of care R2, with approximately three out of four patients achieving a complete response (CR). This approval marks the third indication for Epkinly and first FDA approval for a bispecific combination therapy in lymphoma. Epkinly is being co-developed
More news about: AbbVie
Feb 04, 2026, 04:35 ET Shriram General Insurance Outpaces Industry: Net Profit Surges 26%, Motor Portfolio up 24% YTD (April to December 2025)
a strong Q3, with Gross Direct Premium (GDP) up 19% YoY at ₹1,258 Cr, from ₹1,061Cr outpacing the industry growth of 11% led by its motor book. On a cumulative basis till Q3 FY26, SGI's GDP grew 24% YoY to ₹3,304 Cr, up from ₹2,654 Cr in the corresponding period last year—2.8X times over the industry
More news about: Shriram General Insurance
Jan 30, 2026, 09:09 ET Introducing the New Manheim App--and More Steps Toward a Seamless, More Connected Wholesale Journey
MMR Range, Inventory Curation, and an evolved Condition Report (CR) experience. Collectively, these capabilities are designed to create a friction-free wholesale journey where discovery, decisions and transactions
More news about: Cox Automotive
Jan 29, 2026, 22:30 ET Star Health reports 414% YoY Ind AS Profit growth to ₹449 Cr for Q3 FY26
content:https://www.prnewswire.com/in/news-releases/star-health-reports-414-yoy-ind-as-profit-growth-to-449-cr-for-q3-fy26-302674022.html
More news about: Star Health and Allied Insurance
Jan 29, 2026, 13:17 ET Piramal Pharma Limited annonce ses résultats pour le troisième trimestre et les neuf premiers mois de l'exercice 2026
clients CDMO ₹ 15 Cr. 9MEX2026 - Inclut les éléments exceptionnels du T3EX2026 partiellement compensés par une indemnité d'insolvabilité unique reçu au T1EX2026 à la suite d'une action intentée contre un fournisseur tiers de CHG d'un montant de ₹ 21 Cr. Conférence
More news about: Piramal Pharma Limited
Jan 28, 2026, 13:20 ET NIIT Learning Systems Limited (NIIT MTS) Announces Q3 FY 2026 (October-December 2025) Results
MTS Highlights for Q3, FY 2026Revenue at Rs. 499.7 Cr, up 5% QoQ and 19% YoYEBITDA at Rs. 103.8 Cr, EBITDA margin at 21%, up 46 bps QoQPAT at Rs. 74.3 Cr, up 58% QoQ and 20% YoYAdded 4 new MTS clients taking tally to 107;
More news about: NIIT (USA), INC.
Jan 28, 2026, 08:37 ET New Peer-Reviewed Publication Validates Exceptional Safety and Efficacy of Synovetin OA® for Dog Arthritis
6:625-635. https://doi.org/10.1038/nrrheum.2010.159 PMID: 20924410.Scanzello CR, Umoh E, Pessler F, et al. Osteoarthritis Cartilage. 2009; 17: 1040-1048. https://doi.org/10.1016/j.joca.2009.02.011
More news about: Exubrion Therapeutics
Jan 28, 2026, 08:34 ET Stellar® Rolls Out Massive Upgrades to Data Recovery Software
now enhanced for better MP4 recovery and advanced handling of Cannon® and Nikon® RAW format files (.CR2, .NRW, & .CRW). Same upgrades are also available in the Technician and Toolkit Editions for our high volume, technical users."These upgrades
More news about: Stellar
Jan 27, 2026, 08:00 ET CRŪ Winery Announces New California Distributor Partnership with Serendipity Wines
multimedia:https://www.prnewswire.com/news-releases/cr-winery-announces-new-california-distributor-partnership-with-serendipity-wines-302670696.htmlSOURCE
More news about: CRU Winery
Jan 27, 2026, 08:00 ET Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late-Stage Metastatic Triple-Negative Breast Cancer
demonstrated meaningful clinical responses, including two partial responses (PRs) in trial participants and one confirmed complete metabolic response (CR) in a patient treated under an expanded access program.Clinical Highlights2 of 2 evaluable patients enrolled in
More news about: Kazia Therapeutics Limited
Jan 26, 2026, 08:15 ET Wellspect HealthCare Launches Surity™ Female External Catheter Improving Care for Women Living with Severe Urinary Incontinence
https://www.caregiver.org/resource/caring-someone-incontinence-emotional-and-social-issues/viiiBeeson T, Pittman J, Davis CR. Effectiveness of an External Urinary Device for Female Anatomy and Trends in Catheter-Associated Urinary Tract Infections. J Wound Ostomy Continence
More news about: Wellspect HealthCare
Jan 23, 2026, 07:01 ET IIFL Finance Reports Strong Q3 FY26 PAT of Rs. 501 Crore, up 20% Quarter-on-Quarter
the quarter ended Dec 31, 2025, IIFL Finance reported a consolidated profit after tax of Rs. 501 Cr (pre non-controlling interest) up 20% q-o-q. The company's consolidated AUM rose 9% q-o-q to ₹98,336 Cr, reflecting steady growth driven by strong growth momentum in gold loans business.Key Highlights
More news about: IIFL Finance Limited
Jan 23, 2026, 05:30 ET STL reports Q3 FY'26 results; strengthens technology leadership
results for the quarter ended 31st December 2025. For Q3 FY'26, the Company reported revenues of INR 1,257 Cr and EBITDA of INR 129Cr, a YoY growth of ~26% and ~16%, respectively.
More news about: Sterlite Technologies Ltd - STL
Jan 23, 2026, 05:06 ET Michelin-Starred Chef Joakim Prat's French Galette Is Now Selling Out Daily at Roast CCx
multi-outlet café brands, known for its uncompromising focus on quality, craft, and specialty coffee. Entirely bootstrapped and valued at over ₹250 Cr, Roast CCx is built on a product-first philosophy—doing the classics right, from a clean, honest cup of coffee to globally inspired comfort food. Its
More news about: Roast CCx
Jan 22, 2026, 23:40 ET 晶泰科技賦能萊芒生物取得細胞療法重大成果，以1‰劑量CAR-T實現多位系統性紅斑狼瘡完全緩解出院
年，萊芒生物啟動了針對系統性紅斑狼瘡（SLE）的 IIT 臨床研究，取得重要進展。該療法以僅為常規 CAR-T 治療劑量千分之一（1‰）的極低劑量，在無需清淋預處理、無需中斷原有免疫抑製藥物、且住院時間顯著縮短的條件下，成功使多例中重度 SLE 患者實現無藥物依賴的完全緩解（100% CR）。基於良好的安全性數據，代謝增強型 CD19 CAR-T 療法有望支持門診式給藥模式，為自身免疫性疾病提供一種更便捷、更安全的 「免疫重置」 治療新範式。在惡性血液瘤領域的 IIT 臨床中，代謝增強型 CD19 CAR-T療法同樣表現亮眼。首批入組治療的 20 餘名復發難治性白血病/淋巴瘤患者亦全部達到完全緩解（100%
More news about: 晶泰科技
Jan 22, 2026, 04:00 ET UGRO Capital and Dun & Bradstreet Unveil 4th MSME Sampark Report Showcasing India's MSME Resilience
Co-originating partners and GRO Xstream platform.The Company is backed by marquee institutional investors (raised INR 900+ Cr of equity capital in 2018, INR ~340 Cr in 2023, INR ~258 Cr in 2024 and INR ~1300 in 2025). For more information, please visit:
More news about: Dun & Bradstreet India
Jan 21, 2026, 18:45 ET Noritz to launch new "Commercial One" tankless water heater marketing campaign at the 2026 AHR Expo in Las Vegas
several different types of commercial rack assemblies to meet the hot-water needs of a variety of commercial applications:CR61 Rack: This pre-fabricated, multi-unit racking system is designed for installation on a flat rooftop or in a mechanical room of large commercial
More news about: Noritz
Jan 21, 2026, 08:31 ET Vestibular da Faculdade de Medicina Moinhos de Vento tem inscrições abertas até 26 de janeiro
https://mma.prnewswire.com/media/2865696/03__Faculdade_de_Medicina_Moinhos_cr_dito_Carlos_Macedo_Hospital_Moinhos_de_Vento.jpg
More news about: Hospital Moinhos de Vento
Jan 19, 2026, 09:00 ET VEVOR Redefines the Impact Socket Master Set: The One-Stop Solution for High-Torque Precision, Now Ready for Your Spring Projects
VEVOR Impact Socket Master Sets are engineered to withstand repeated high-torque impact without deforming or losing performance. Forged from durable CR-V alloy steel, each socket is designed to hold up where ordinary tools often fall short.Precision matters just as much as strength. A 6-point
More news about: VEVOR
Jan 16, 2026, 13:54 ET IBV Auto: CR-V, Clio e Jetta lideram altas, enquanto Peugeot 206 e VW Golf registram as maiores quedas entre os usados em 2025
usados no país, Honda, Toyota e Renault foram as marcas que registraram valorização superior a 7% no acumulado do ano. Na Honda, o CR-V apresentou desempenho expressivo, com alta de 26,9% em 2025. Modelos de grande volume também contribuíram para o resultado da marca, como o Civic,
More news about: Banco BV
Jan 16, 2026, 09:03 ET Top Crunch Fitness Franchise CR Fitness Holdings Surpasses 1 Million Member Milestone
designed to support individual goals.About CR Fitness Holdings, LLCCR Fitness Holdings, LLC is the leading franchisee of Crunch Fitness, and led by a management team with over 150 years of combined experience in the fitness industry. CR Fitness is on track to operate 110 locations nationwide
More news about: CR Fitness Holdings, LLC.
Jan 15, 2026, 20:00 ET Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs
efficacious dose range of 1.8-2.4 mg/kg, the ORR was 28.6% (6/21). In addition, one patient in each of the three dose groups achieved a complete response (CR). These results demonstrated the potent anti-tumor activity of ATG-022 across all levels of CLDN18.2 expression. Promising frontline combination
More news about: Antengene Corporation Limited
Jan 15, 2026, 14:07 ET Sun Pharma Announces the Availability of UNLOXCYT™ (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma (aCSCC)
pivotal CK-301-101 clinical trial. This study showed improvements in objective response rates (including more patients who achieved a complete response [CR]) and duration of response. The safety data did not change from the original UNLOXCYT label.Many patients in the pivotal trial experienced durable
More news about: Sun Pharma
Jan 14, 2026, 16:30 ET TECVAYLI® monotherapy demonstrates superior progression-free and overall survival versus standard of care as early as first relapse in patients with multiple myeloma predominantly refractory to anti-CD38 therapy and lenalidomide
TECVAYLI® for a reduced dosing frequency of 1.5 mg/kg every two weeks in patients with RRMM who achieved and maintained a complete response (CR) or better for a minimum of six months. Since FDA approval, more than 20,800 patients have been treated worldwide with TECVAYLI®.The
More news about: Johnson & Johnson